PHILIP MORRIS INTERNATIONAL (PM)       102.485  -0.11 (-0.1%)

102.485  -0.11 (-0.1%)

US7181721090 - Common Stock


Fundamental Rating

4

Taking everything into account, PM scores 4 out of 10 in our fundamental rating. PM was compared to 9 industry peers in the Tobacco industry. Both the profitability and the financial health of PM get a neutral evaluation. Nothing too spectacular is happening here. PM is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

6

PM's Return On Assets of 21.42% is amongst the best returns of the industry. PM outperforms 83% of its industry peers. The industry average Return On Assets is 12.77%.
PM's Profit Margin of 27.50% is amongst the best returns of the industry. PM outperforms 83% of its industry peers. The industry average Profit Margin is 18.57%.

PM has a Piotroski-F score of 6.00. This indicates an average health and profitability for PM.
VS Industry

ROA (21.42%) VS Industry: 83% outperformed.

3.18
30.57

Profit Margin (27.5%) VS Industry: 83% outperformed.

3.76
31.36

Valuation

Valuation Rating

0

With a Price/Earnings Ratio of 17.31, PM is valued on the expensive side.
The Forward Price/Earnings Ratio of 17.75 indicates a rather expensive current valuation of PM.
Compared to an average industry Price/Earning Ratio of 10.17, PM is valued more expensive than its industry peers. On top of this 100% of the companies listed in the same industry are cheaper than PM!

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates PM does not grow enough to justify the current Price/Earnings ratio.
Compared to an average industry Enterprise Value to EBITDA ratio of 8.96, PM is valued more expensive than its industry peers. 100% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (17.31) VS Industry: 0% outperformed.

17.31
8.48

Enterprise Value/ EBITDA (13.07) VS Industry: 0% outperformed.

13.07
4.65

Growth

Growth Rating

4

The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
PM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.00%.
PM shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 6.26% yearly.
The Earnings Per Share is expected to grow by 4.47% on average over the next 5 years.

The Revenue has been growing slightly by 3.15% in the past year.
Measured over the past 5 years, PM shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
Based on estimates for the next 5 years, PM will show a small growth in Revenue. The Revenue will grow by 4.69% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS6.26% 5.98% -1% -8.8% -2.46% 2.66% 4.47%
Revenue3.31% 1.96% 3.15% -1.51% 0.23% 3.32% 4.69%

Health

Health Rating

4

PM has an Altman-Z score of 4.81. This indicates that PM is financially healthy and little risk of bankruptcy at the moment.
PM has one of the better Altman-Z scores in its industry. It is much better than the industry average of 3.90. PM has a better score than 100% of its industry peers.
The Piotroski-F score of PM is 6.00. This is a neutral score and indicates average health and profitability for PM.
PM has a Current Ratio of 0.92. This is a bad value and indicates that PM is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 2.49, PM is worse placed to pay its short term obligations than its industry peers.
A Quick Ratio of 0.57 indicates that PM may have some problems paying its short term obligations.
When comparing the Quick Ratio of PM to the average industry Current Ratio of 1.57, PM is less able to pay its short term obligations than its industry peers.
VS Industry

Quick Ratio (0.57) VS Industry: 28% outperformed.

0.36
10.72

Current Ratio (0.92) VS Industry: 28% outperformed.

0.50
10.76

Altman-Z (4.81) VS Industry: 100% outperformed.

1.31
4.81

Dividend

Dividend Rating

5

PM has a Yearly Dividend Yield of 4.99%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.41, PM pays a better dividend.
PM has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of PM has a limited annual growth rate of 3.14%.

Compared to an average industry Dividend Yield of 6.44, PM's dividend is way lower than its industry peers. On top of this 80% of the companies listed in the same industry pay a better dividend than PM!
PM's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
PM pays out 89.35% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (4.99%) VS Industry: 20% outperformed.

1.06
8.37

PHILIP MORRIS INTERNATIONAL102.485

NYSE:PM (2/6/2023, 1:20:06 PM)-0.11 (-0.1%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Tobacco
Earnings (Last) 10-20 2022-10-20/bmo Earnings (Next) 02-08 2023-02-08/amc
Inst Owners 75.39% Inst Owner Change -0.79%
Ins Owners 0.15% Ins Owner Change 0%
Market Cap 158.87B Analysts 77.86
Price Target 107.36 (4.76%)

Dividend
Industry RankSector Rank
Dividend Yield 4.99%
Dividend Growth(5Y) 3.14% DP 89.35%
Div Incr Years 14 Div Non Decr Years 14
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 11.66%
Min EPS beat(2) 9.29% Max EPS beat(2) 14.04%
EPS beat(4) 3 Avg EPS beat(4) 5.91%
Min EPS beat(4) -1.24% Max EPS beat(4) 14.04%
Revenue beat(2) 2 Avg Revenue beat(2) 9.7%
Min Revenue beat(2) 6.65% Max Revenue beat(2) 12.74%
Revenue beat(4) 4 Avg Revenue beat(4) 5.51%
Min Revenue beat(4) 1.24% Max Revenue beat(4) 12.74%
PT rev (1m) 0.34% PT rev (3m) 4%
EPS NQ rev (1m) -0.08% EPS NQ rev (3m) 1.3%
EPS NY rev (1m) 0% EPS NY rev (3m) -3.59%
Revenue NQ rev (1m) 2.64% Revenue NQ rev (3m) 2.94%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.21%

Valuation
Industry RankSector Rank
PE 17.31
Fwd PE 17.75
P/S 5.01
P/FCF 14.82
P/OCF 13.53
P/B N/A
P/tB N/A
EV/EBITDA 13.07
EPS(TTM) 5.92 EY 5.78%
EPS(NY) 5.78 Fwd EY 5.63%
FCF(TTM) 6.92 FCFY 6.75%
OCF(TTM) 7.57 OCFY 7.39%
SpS 20.46 BVpS -5.89
TBVpS -11.28 PEG (NY) N/A
PEG (5Y) 2.76

Profitability
Industry RankSector Rank
ROA 21.42%
ROE N/A
ROIC 42.76%
ROICexc 55.96%
ROICexgc 107.63%
OM 39.24%
PM 27.5%
GM 65.47%
ROICexgc(3y) 102.98% ROICexcg growth 3Y 0.7%
ROICexcg growth 5Y 0.47% ROICexc(3y) 53.28%
ROICexc growth 3Y 3.01% ROICexc growth 5Y 2.72%
OM growth 3Y 3.03% OM growth 5Y 0.55%
PM growth 3Y 2.77% PM growth 5Y 2.12%
GM growth 3Y 2.24% GM growth 5Y 0.98%
F-Score 6 Asset Turnover 0.78

Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.54
Debt/EBITDA 2
Cap/Depr 86.58%
Profit Quality 122.97%
Current Ratio 0.92
Quick Ratio 0.57
Altman-Z 4.81
F-Score 6 WACC 7.32%
ROIC/WACC 14.71 Cap/Depr(3y) 74.9%
Cap/Depr(5y) 109.36% Profit Quality(3y) 122.34%
Profit Quality(5y) 118.23%

Growth
EPS 1Y -1% EPS 3Y 5.98%
EPS 5Y 6.26% EPS growth Q2Q -3.16%
EPS Next Y -8.8% EPS Next 2Y -2.46%
EPS Next 3Y 2.66% EPS Next 5Y 4.47%
Revenue growth 1Y 3.15% Revenue growth 3Y 1.96%
Revenue growth 5Y 3.31% Revenue growth Q2Q -1.11%
Revenue Next Year -1.51% Revenue Next 2Y 0.23%
Revenue Next 3Y 3.32% Revenue Next 5Y 4.69%
EBIT growth 1Y -5.6% EBIT growth 3Y 5.05%
EBIT growth 5Y 3.88% EBIT Next Year 0.81%
EBIT Next 3Y 4.7% EBIT Next 5Y 5.95%
FCF growth 1Y 14.61% FCF growth 3Y 11.74%
FCF growth 5Y 10.19% OCF growth 1Y 17.73%
OCF growth 3Y 8.08% OCF growth 5Y 8.18%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA